Estradiol Valerate

Delestrogen · Progynon Depot

Estradiol HRT IM SubQ FDA/EMA Label

Half-life

3.5 days

Time to Peak

2.5 days

Steady State

~18 days

Bioavailability

100%

Dose Range

2–10 mg

Frequency

every 3 days

Overview

Estradiol Valerate is an injectable estrogen ester commonly used in feminizing hormone therapy. It provides stable estradiol levels with a half-life of about 3.5 days, typically dosed every 5-7 days.

Mechanism of Action

Prodrug: valerate ester is hydrolyzed in vivo, releasing active 17β-estradiol. Binds estrogen receptors (ERα and ERβ) to produce feminizing effects.

Dosing Information

Route Dose Range Half-life Tmax Frequency
Intramuscular (IM) 2–10 mg 3.5 days 2.5 days every 3 days, every 5 days, Weekly
Subcutaneous (SubQ) 2–10 mg 5 days 3.5 days every 5 days, Weekly

Common Side Effects

  • · Breast tenderness and development
  • · Mood changes
  • · Headache
  • · Nausea
  • · Injection site pain
  • · Weight redistribution
  • · Decreased libido (variable)

Monitoring Recommendations

Estradiol and testosterone at trough every 3 months for first year, then every 6-12 months. Prolactin at baseline and annually. Lipid panel and liver enzymes annually. Potassium if on spironolactone.

Storage & Handling

Room Temperature

Store at 20-25°C.

General

Protect from light. Do not freeze.

Community Notes

IM injection in the thigh or glute is standard. Many trans women prefer every-5-day dosing to minimize end-of-cycle lows. Drawing labs at trough (just before next injection) gives the most useful reference point. SubQ is off-label but increasingly used with good results.

Used in Regimens

6 regimens

EV + Bicalutamide Pathway

Estradiol valerate with bicalutamide non-steroidal anti-androgen. Bicalutamide blocks androgen receptors without affecting LH/FSH or testosterone production — testosterone remains high but its effects are blocked. Liver monitoring required. Growing in popularity as a spironolactone and CPA alternative.

EV injection as primary oestrogen.

hrt_fem
Primary

EV + CPA (European Pathway)

Estradiol valerate injections with low-dose cyproterone acetate (CPA) anti-androgen. Standard in Germany, Netherlands, and much of Europe. CPA at low dose (6.25–12.5mg/day alternate days) provides potent androgen suppression with significantly lower meningioma risk than legacy high doses.

EV injection as primary oestrogen.

hrt_fem
Primary

EV Injection Monotherapy — DIY Community

Estradiol Valerate injection monotherapy per community consensus: 4–7mg every 5 days (IM) targeting trough E2 >200 pg/mL to suppress testosterone without an anti-androgen. The community-driven approach to transfeminine HRT — higher estradiol targets than clinical guidelines. Every-5-day schedule is community standard; clinical biweekly schedule causes unacceptable level swings.

4–7mg IM every 5 days. Trough target: >200 pg/mL. Adjust based on trough bloods.

hrt_fem
Primary

EV Monotherapy (High-Dose Clinical)

High-dose estradiol valerate monotherapy targeting oestradiol levels high enough to suppress testosterone without any anti-androgen. Clinical version — biweekly schedule as prescribed. See community regimen C4 for DIY every-5-day variant.

EV monotherapy high dose targeting trough E2 >200 pg/mL.

hrt_fem
Primary

Transfeminine HRT — Classic Stack

Estradiol valerate injections with spironolactone anti-androgen and progesterone added after 3 months once oestradiol levels are stable. The most common transfeminine HRT regimen globally.

hrt_fem
Primary

Transfeminine HRT — Powers Method

Dr Will Powers' EV monotherapy pathway. High-dose injectable oestradiol to suppress testosterone without anti-androgens, progesterone added rectally for bioavailability. Evidence-based and widely used in the DIY community.

hrt_fem
Primary

Data Sources

Related Tools

Track Estradiol Valerate with Doseline

Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.

Join the waitlist

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.